The FDA has approved a clinical trial for the ultra-rare disease Mucolipidosis Type IV that will take place at UMass Chan Medical School: https://direc.to/p3N5
Mass General Brigham researchers are co-leading the MLIV trial.
#ClinicalTrial #GeneTherapy #RareDisease @mgbresearch.bsky.social
